QR Code

Expression profile of plasma microRNAs and target genes in patients with complicated pregnancy

Show other versions (1)

Aim: to assess features of placental transcriptome in patients with complicated pregnancy course and outcome.Materials and Methods. A prospective observational comparative study in parallel groups was carried out by examining 44 patients divided into three groups: group 1 included 13 pregnant women...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. D. Umerova, S. S. Alyadinova, M. J. Khonjonova, R. A. Balakadasheva, E. E. Menadzhiev, D. I. Kharchuk, D. O. Leus, G. I. Islyamova, M. I. Islyamova, S. L. Abkarimova, D. S. Kasabyan, L. E. Sorokina
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2023-07-01
Series:	Акушерство, гинекология и репродукция
Subjects:	placental dysfunction pregnancy complications preeclampsia pe fetal growth retardation fgr transcriptome mirna
Online Access:	https://www.gynecology.su/jour/article/view/1688
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression profile of plasma microRNAs and target genes in patients with complicated pregnancy
by: D. G. Pashkovsky, et al.
Published: (2023-05-01)

Maternal gut microbiome and its impact on developing idiopathic late fetal growth retardation
by: M. E. Zhelezova, et al.
Published: (2025-01-01)

Predicting fetal growth retardation: mathematical modeling
by: E. V. Kudryavtseva, et al.
Published: (2023-01-01)

Clinical significance of assessing autoantibody level in diagnostics of early and late fetal growth retardation
by: I. V. Ignatko, et al.
Published: (2022-09-01)

Angiogenic factors (sFlt-1, PlGF) in twin pregnancy with placentaassociated complications
by: M. A. Kurtser, et al.
Published: (2022-11-01)

Thrombophilia in the pathogenesis of fetal growth retardation
by: E. A. Orudzhova, et al.
Published: (2021-05-01)

Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation
by: E. A. Orudzhova
Published: (2022-01-01)

Reduced circulating NrCAM as a biomarker for fetal growth restrictionResearch in context
by: Lucy A. Bartho, et al.
Published: (2025-08-01)

<i>MTRR</i> gene rs1801394 polymorphism is associated with neonatal birth weight in pregnant women with fetal growth retardation
by: Yu. N. Reshetnikova, et al.
Published: (2024-03-01)

THE ROLE OF VASCULAR GROWTH FACTORS IN THE PATHOGENESIS OF PLACENTAL INSUFFICIENCY
by: E. V. Volkova, et al.
Published: (2016-05-01)

Pathology of placenta placement and thrombophilia: an inconspicuous connection
by: V. B. Zubenko, et al.
Published: (2025-03-01)

Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies
by: D. R. Eremeeva, et al.
Published: (2024-09-01)

Stillbirth and fetal growth restriction
by: V. G. Volkov, et al.
Published: (2023-03-01)

Polymorphic loci of the <i>ESR1<i/> gene are associated with the risk of developing preeclampsia with fetal growth retardation
by: O. V. Golovchenko, et al.
Published: (2021-01-01)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia
by: E. A. Orudzhova, et al.
Published: (2022-05-01)

Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration prediction
by: Daisuke Katsura, et al.
Published: (2025-12-01)

Gestational complications of the prothrombin G20210A mutation related to prothrombin activity
by: M. G. Nikolaeva, et al.
Published: (2020-07-01)

Multiple intraplacental hematomas preceding clinical deterioration in preeclampsia with severe features: A case report
by: Nicholas A. Orlando, MSc, et al.
Published: (2025-09-01)

Clinical observation of delivery in a COVID-19-convalescent woman with preeclampsia developing fetal distress during preterm labor
by: E. Iu. Iupatov, et al.
Published: (2023-09-01)

Newborn weight is associated with the maternal F13A1 gene rs5985 polymorphism
by: O. V. Golovchenko, et al.
Published: (2021-07-01)

Transcriptomic profile assessment for preeclampsia prediction and early diagnostics
by: A. V. Melnik, et al.
Published: (2024-07-01)

THE MODERN VIEW OF THE MANAGEMENT OF PREGNANCY IN HIV INFECTION
by: I. O. Makarov, et al.
Published: (2016-09-01)

Nutrients and environmental toxicants: effect on placental function and fetal growth
by: G. C. Di Renzo
Published: (2024-03-01)

Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation
by: Rune Schjetlein, et al.
Published: (1997-06-01)

POSSIBILITIES OF FORECASTING EARLY PREECLAMPSIA IN 11-13 WEEK OF GESTATION
by: L. D. Belotserkovtseva, et al.
Published: (2019-05-01)

ROLE OF GENETIC THROMBOPHILIA IN THE DEVELOPMENT OF THROMBOEMBOLIC AND OBSTETRIC COMPLICATIONS
by: D. L. Kapanadze, et al.
Published: (2018-02-01)

The context signals of mitochondrial miRNAs (mitomiRs) of mammals
by: O. V. Vishnevsky, et al.
Published: (2023-01-01)

Expression and Clinical Significance of Irisin in Serum and Placenta Tissues of Pregnant Women with Severe Preeclampsia
by: Ren Y, et al.
Published: (2025-05-01)

The relationships between pregnancy-associated protein A levels, placental localization and fetal birth weight
by: A. E. Güler, et al.
Published: (2019-02-01)

Prediction of hypertensive disorders in pregnant women in the «gray» risk zone following combined first-trimester screening
by: N. V. Mostova, et al.
Published: (2024-05-01)

Hypertension in pregnancy: use of antihypertensive drugs
by: Tore Henriksen
Published: (1997-02-01)

MicroRNAs as novel biomarkers for prenatal fetal congenital heart disease – systematic literature review
by: Adrianna Kondracka, et al.
Published: (2025-07-01)

Genetic thrombophilia and antiphospholipid antibodies in women with early and late preeclampsia: a retrospective cohort study
by: A. S. Antonova, et al.
Published: (2025-03-01)

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023-03-01)

INCREASING THE NITRIC OXIDE BIOAVAILABILITY AND ADAPTATION OF MATERNAL-PLACENTAL-FETAL HEMODYNAMICS IN THE TREATMENT OF THE PLACENTAL INSUFFICIENCY
by: V. S. Gimbut, et al.
Published: (2013-12-01)

Markers of systemic endotheliosis in early-onset preeclampsia relapse
by: M. G. Nikolaeva, et al.
Published: (2023-09-01)

Association between placental insufficiency and manifestations of preeclampsia
by: A. N. Strizhakov, et al.
Published: (2018-11-01)

The importance of pathological insulin resistance and hyperinsulinemia in the pathogenesis of preeclampsia
by: I. S. Lipatov, et al.
Published: (2020-11-01)

Quantitative assessment of fetal blood flow in dogs
by: Anastasia V. Shumeyko, et al.
Published: (2025-12-01)